22157.jpg
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
April 23, 2024 05:18 ET | Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
22157.jpg
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
April 17, 2024 03:13 ET | Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
22157.jpg
Diet Pills Global Market Report 2024: The Rise of Plant-Based and Technological Innovations
January 24, 2024 05:18 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Diet Pills Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest market research sheds light on the remarkable...
St Louis Bariatrics Logo.jpg
Zepbound™ New Injectable Weight Loss Medication Coming to St. Louis
November 10, 2023 11:00 ET | St. Louis Bariatrics
St Louis, MO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Food and Drug Administration has granted approval for Zepbound™, an innovative weight loss medication developed by Eli Lilly. In clinical trials,...
22157.jpg
Key Trends and Opportunities in the Global Weight Loss Products and Services Market to 2026
August 03, 2021 04:23 ET | Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Weight Loss Products and Services Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for weight...